Home  /  Resource Library  /  Efficacy and Safety of Tisagenlecleucel in Adult Patients with Relapsed/Refractory Follicular Lymphoma: Interim Analysis of the Phase 2 Elara Trial

Efficacy and Safety of Tisagenlecleucel in Adult Patients with Relapsed/Refractory Follicular Lymphoma: Interim Analysis of the Phase 2 Elara Trial

ASH 2020: Prelminary results of a study examining CAR T cell Tisagenlecleucel for treatment of relasped follicular lymphoma.